scholarly journals 42. The dangers of herbal weight loss supplements: A case report of drug-induced liver injury secondary to GARCINIA CAMBOGIA ingestion and literature review

Pathology ◽  
2020 ◽  
Vol 52 ◽  
pp. S147 ◽  
Author(s):  
R.E. McCarthy ◽  
D.G. Bowen ◽  
S.I. Strasser ◽  
C. McKenzie
2013 ◽  
Vol 2 (2) ◽  
pp. 81-83
Author(s):  
Dan-ying Cheng ◽  
Xiao-mei Wang ◽  
Wei-ni Ou ◽  
Hui-chun Xing

Abstract Drug-induced liver injury (DILI) is defined as injury to the liver caused by exposure to a drug or some drugs. The number of cases suffering from DILI has been increasing. There are few clinical features specifically associated with DILI. The recognition and diagnosis of DILI is difficult. In this report, we described a DILI case caused by herbal remedies.


2009 ◽  
Vol 15 (19) ◽  
pp. 2414 ◽  
Author(s):  
Giovanni Tarantino ◽  
Martina Gilda Pezzullo ◽  
Matteo Nicola Dario di Minno ◽  
Francesco Milone ◽  
Luigi Sossio Pezzullo ◽  
...  

2020 ◽  
Vol 8 (12) ◽  
pp. 3105-3109
Author(s):  
Miguel González‐Muñoz ◽  
Jaime Monserrat Villatoro ◽  
Eva Marín‐Serrano ◽  
Stefan Stewart ◽  
Belén Bardón Rivera ◽  
...  

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S1271
Author(s):  
Ashina D. Singh ◽  
Scott A. Manski ◽  
Nathalie H. Urrunaga

Author(s):  
Manuel de la Torre-Aláez ◽  
Mercedes Iñarrairaegui

Autoimmune hepatitis (AIH) was the first liver disease for which an effective therapeutic intervention was carried out, using prednisolone; its usefulness was demonstrated in several clinical trials. Nevertheless, AIH still remains a difficult diagnosis in some cases, because it is necessary to dismiss other possible diagnoses, and perhaps due to it being a heterogeneous disease. The relationship between drug-induced liver injury (DILI) and AIH is complex and not fully understood. There are three possible scenarios: (1) DILI with a strong immunoallergic component mimicking AIH; (2) AIH mimicking a DILI due to drug exposure and (3) AIH triggered by exposure to an offending drug (drug-induced AIH). Drug-induced AIH is well described and documented for some drugs such as nitrofurantoin and minocycline. Histologically distinguishing DILI from AIH remains a challenge. We present an interesting case report which met serologic criteria and histological confirmation to establish AIH, but discontinuation of a suspected drug resolved hypertransaminasaemia.


Sign in / Sign up

Export Citation Format

Share Document